Loading...
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. PRO displays effects on cellular proliferation and invasion, on the immune system, on the angiogenic cascade, a...
Na minha lista:
| Udgivet i: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cancer Intelligence
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5102691/ https://ncbi.nlm.nih.gov/pubmed/27899953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.680 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|